Global X ReSolve Adaptive Asset Allocation Corporate Class ETF (HRAA) Share Price

It sounds like you have no clue about what Pulte is doing about the GSEs,
Fnma

clinically meaningful and statistically significant extension of survival for patients with both nGBM and rGBM compared with contemporaneous, matched external controls who received SOC alone”

Anyone with a functioning brain and an unbiased view knows that when this language is used in

Saw it already.Makes a lot of sense! 

$SANP$$$$ with almost 20 billion o/s what do you think .01?
https://x.com/transferledger/status/1912899403796394356

Think of it as a ‘Yacht to Space.’ The ‘Yacht To Space,’ would carry 15 to 20 passengers up to 68,000 feet, the edge of space. Lawson said the price for a ticket on the ‘Yacht To Space’ would cost around $50,000.

Vietnam fast tracks four Trump golf courses  in exchange for tariff relief.

Have you ever been sat in on guidance meetings with the FDA, boi?

Could well be. Still, PD pump followed the exact same pattern: claim a very short term material development and then fail to deliver. No one is falling for the puffery any longer - and this puffery is part of the reason, IMO, that no major IB covers Anavex.

MRNJ>October, 2022>preparing>informing>931 Days

MRNJ
OTCMarkets
Press Release
October 3, 2022
“is pleased to announce that the Company is officially canceling any/all plans for the reverse split that was previously announced and filed with regulato

Check out this YouTube video uploaded today on vgtl
https://www.youtube.com/watch?v=wpJrsxP1M1M

You are always good for a laugh.

There's no loans to dilute insiders gave a loan to vgtl but they are restricted until November 

PLX, off the 52 week low
https://investorshub.advfn.com/uimage/uploads/2025/4/20/zhiohIMG_6225.gif

No dilution insiders cant sell even if they wanted to until November 

Yesssir! Same sentiment here, I meant, "spectacular" meaning... it looks as if we finally get an official launch"...slow and steady wins the race.

All the best ProfitChaser,
SOG

I've been in the stock for 10 years, no balance sheet to speak of, just stock trading, sure hope they file soon, or they go to the expert market in 10 days.

There is certainly one possibility to believe that the FDA have not given any feedback on any PD trial design from Anavex, which is that the company hasn't put one to the FDA to comment on.

The only explanation I have for your Rett report is that Missling was very soon after overruled on that decision -- which was a reasonable thing for the Board to do. I can make no other sense of a statement that was immediately proven wrong, since even a lie would have to serve a purpose.

JD is lucky he didn't get a deacon and a booth.

There's no reason to believe that the FDA has given its final feedback on the PD trial design.

I trust they’ll get it done.

We don’t need another study, they’ve done enough to be granted MAA approval.

“Based on the content of the article and standard practices for JAMA Oncology, the reviewers likely had access to:
Manuscript Details:
Study Design: The article describes a nonrandomized contro

...